Status:
COMPLETED
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
Lead Sponsor:
Cooperative Study Group A for Hematology
Conditions:
HEMATOLOGIC MALIGNANCIES
Eligibility:
All Genders
15-55 years
Brief Summary
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.
Detailed Description
Primary end points are treatment-related mortality and engraftment. Secondary end points are regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.
Eligibility Criteria
Inclusion
- Patients should have an unrelated donor who is matched for HLA-A and -B by serology and for -DRB1 by molecular typing.
Exclusion
- Patients should not have major illness or organ failure
- Patients must not have a psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible.
- Patients must not be pregnant or lactating.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00770523
Start Date
December 1 2003
End Date
December 1 2008
Last Update
June 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736